Factors Involved in Heterologous Expression of Proteins in E. Coli Host

Overview

Journal Arch Microbiol

Specialty Microbiology

Date 2023 Apr 29

PMID 37120438

Authors

Mahin Pouresmaeil

Shahnam Azizi-Dargahlou

Affiliations

Soon will be listed here.

Abstract

The production of recombinant proteins is one of the most significant achievements of biotechnology in the last century. These proteins are produced in the eukaryotic or prokaryotic heterologous hosts. By increasing the omics data especially related to different heterologous hosts as well as the presence of new amenable genetic engineering tools, we can artificially engineer heterologous hosts to produce recombinant proteins in sufficient quantities. Numerous recombinant proteins have been produced and applied in various industries, and the global recombinant proteins market size is expected to be cast to reach USD 2.4 billion by 2027. Therefore, identifying the weakness and strengths of heterologous hosts is critical to optimize the large-scale biosynthesis of recombinant proteins. E. coli is one of the popular hosts to produce recombinant proteins. Scientists reported some bottlenecks in this host, and due to the increasing demand for the production of recombinant proteins, there is an urgent need to improve this host. In this review, we first provide general information about the E. coli host and compare it with other hosts. In the next step, we describe the factors involved in the expression of the recombinant proteins in E. coli. Successful expression of recombinant proteins in E. coli requires a complete elucidation of these factors. Here, the characteristics of each factor will be fully described, and this information can help to improve the heterologous expression of recombinant proteins in E. coli.

Citing Articles

One Health Approach to the Computational Design of a Lipoprotein-Based Multi-Epitope Vaccine Against Human and Livestock Tuberculosis.

Shey R, Nchanji G, Stong T, Yaah N, Shintouo C, Yengo B Int J Mol Sci. 2025; 26(4).

PMID: 40004053 PMC: 11855821. DOI: 10.3390/ijms26041587.

Harnessing the potential of chloroplast-derived expression elements for enhanced production of cellulases in .

Siddiqui A, Iqbal M, Ali A, Fatima I, Ali H, Shehzad A PeerJ. 2025; 13:e18616.

PMID: 39902317 PMC: 11789652. DOI: 10.7717/peerj.18616.

A suite of pre-assembled, pET28b-based Golden Gate vectors for efficient protein engineering and expression.

Gaur D, Wohlever M bioRxiv. 2025; .

PMID: 39868162 PMC: 11761132. DOI: 10.1101/2025.01.13.632842.

Advances and applications of CRISPR/Cas-mediated interference in .

Lim X, Zhang C, Chen X Eng Microbiol. 2024; 4(1):100123.

PMID: 39628789 PMC: 11611006. DOI: 10.1016/j.engmic.2023.100123.

A comparative guide to expression systems for phage lysin production.

Cremelie E, Vazquez R, Briers Y Essays Biochem. 2024; 68(5):645-659.

PMID: 39290148 PMC: 11652153. DOI: 10.1042/EBC20240019.

References

Giacalone M, Gentile A, Lovitt B, Berkley N, Gunderson C, Surber M . Toxic protein expression in Escherichia coli using a rhamnose-based tightly regulated and tunable promoter system. Biotechniques. 2006; 40(3):355-64. DOI: 10.2144/000112112. View

Booth W, Schlachter C, Pote S, Ussin N, Mank N, Klapper V . Impact of an N-terminal Polyhistidine Tag on Protein Thermal Stability. ACS Omega. 2018; 3(1):760-768. PMC: 5793033. DOI: 10.1021/acsomega.7b01598. View

Cserjan-Puschmann M, Lingg N, Engele P, Kross C, Loibl J, Fischer A . Production of Circularly Permuted Caspase-2 for Affinity Fusion-Tag Removal: Cloning, Expression in , Purification, and Characterization. Biomolecules. 2020; 10(12). PMC: 7760212. DOI: 10.3390/biom10121592. View

Studier F, Moffatt B . Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J Mol Biol. 1986; 189(1):113-30. DOI: 10.1016/0022-2836(86)90385-2. View

Sahdev S, Khattar S, Saini K . Production of active eukaryotic proteins through bacterial expression systems: a review of the existing biotechnology strategies. Mol Cell Biochem. 2007; 307(1-2):249-64. DOI: 10.1007/s11010-007-9603-6. View

Sarduy E, Munoz A, Trejo S, Chavez Planes M . High-level expression of Falcipain-2 in Escherichia coli by codon optimization and auto-induction. Protein Expr Purif. 2012; 83(1):59-69. DOI: 10.1016/j.pep.2012.03.008. View

Jo B . An Intrinsically Disordered Peptide Tag that Confers an Unusual Solubility to Aggregation-Prone Proteins. Appl Environ Microbiol. 2022; 88(7):e0009722. PMC: 9004385. DOI: 10.1128/aem.00097-22. View

Strocchi M, Ferrer M, Timmis K, Golyshin P . Low temperature-induced systems failure in Escherichia coli: insights from rescue by cold-adapted chaperones. Proteomics. 2005; 6(1):193-206. DOI: 10.1002/pmic.200500031. View

Khan K . Gene expression in Mammalian cells and its applications. Adv Pharm Bull. 2013; 3(2):257-63. PMC: 3848218. DOI: 10.5681/apb.2013.042. View

10.

Deng T, Ge H, He H, Liu Y, Zhai C, Feng L . The heterologous expression strategies of antimicrobial peptides in microbial systems. Protein Expr Purif. 2017; 140:52-59. DOI: 10.1016/j.pep.2017.08.003. View

11.

Berkmen M . Production of disulfide-bonded proteins in Escherichia coli. Protein Expr Purif. 2011; 82(1):240-51. DOI: 10.1016/j.pep.2011.10.009. View

12.

Gong L, Yang Z, Zhang F, Gao W . Cytokine conjugates to elastin-like polypeptides. Adv Drug Deliv Rev. 2022; 190:114541. DOI: 10.1016/j.addr.2022.114541. View

13.

Carmignotto G, Azzoni A . On the expression of recombinant Cas9 protein in E. coli BL21(DE3) and BL21(DE3) Rosetta strains. J Biotechnol. 2019; 306:62-70. DOI: 10.1016/j.jbiotec.2019.09.012. View

14.

Verma D, Daniell H . Chloroplast vector systems for biotechnology applications. Plant Physiol. 2007; 145(4):1129-43. PMC: 2151729. DOI: 10.1104/pp.107.106690. View

15.

Oey M, Lohse M, Kreikemeyer B, Bock R . Exhaustion of the chloroplast protein synthesis capacity by massive expression of a highly stable protein antibiotic. Plant J. 2008; 57(3):436-45. DOI: 10.1111/j.1365-313X.2008.03702.x. View

16.

Tochio N, Umehara T, Nakabayashi K, Yoneyama M, Tsuda K, Shirouzu M . Solution structures of the DNA-binding domains of immune-related zinc-finger protein ZFAT. J Struct Funct Genomics. 2015; 16(2):55-65. PMC: 4427657. DOI: 10.1007/s10969-015-9196-3. View

17.

Losen M, Frolich B, Pohl M, Buchs J . Effect of oxygen limitation and medium composition on Escherichia coli fermentation in shake-flask cultures. Biotechnol Prog. 2004; 20(4):1062-8. DOI: 10.1021/bp034282t. View

18.

Makrides S . Strategies for achieving high-level expression of genes in Escherichia coli. Microbiol Rev. 1996; 60(3):512-38. PMC: 239455. DOI: 10.1128/mr.60.3.512-538.1996. View

19.

Jenny R, Mann K, Lundblad R . A critical review of the methods for cleavage of fusion proteins with thrombin and factor Xa. Protein Expr Purif. 2003; 31(1):1-11. DOI: 10.1016/s1046-5928(03)00168-2. View

20.

Ghavim M, Abnous K, Arasteh F, Taghavi S, Nabavinia M, Alibolandi M . High level expression of recombinant human growth hormone in : crucial role of translation initiation region. Res Pharm Sci. 2017; 12(2):168-175. PMC: 5385732. DOI: 10.4103/1735-5362.202462. View